{
  "id": 20482412,
  "title": "GSK won U.S. approval for its second lung cancer drug from the Nuvalent deal",
  "url": "https://urgent.news/2026/11/17/gsk-won-u-s-approval-for-its-second-lung-cancer-drug-from-the",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-17T19:00:23.000Z",
  "source": {
    "name": "Quartz",
    "slug": "quartz",
    "url": "https://qz.com/gsk-neladalkib-nelkarmi-fda-approval-nuvalent-111726"
  },
  "original_language": "en",
  "account": null,
  "summary": "The FDA granted accelerated approval to neladalkib, sold as Nelkarmi, for ALK-positive non-small cell lung cancer",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Seeking Alpha News",
        "title": "GSK wins FDA nod for lung cancer therapy added from Nuvalent buyout",
        "url": "https://urgent.news/2026/11/17/gsk-wins-fda-nod-for-lung-cancer-therapy-added-from-nuvalent-buyout",
        "published": "2026-11-17T18:26:44.000Z"
      },
      {
        "outlet": "Investing.com",
        "title": "GSK wins FDA approval for lung cancer drug Nelkarmi",
        "url": "https://urgent.news/2026/11/17/gsk-wins-fda-approval-for-lung-cancer-drug-nelkarmi",
        "published": "2026-11-17T18:48:19.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}